Healthcare101

  Blood Screening Market in terms of revenue was estimated to be worth $2.4 billion in 2023 and is poised to reach $3.4 billion by 2028, growing at a CAGR of 7.2% from 2023 to 2028 according to a new report by MarketsandMarkets™. Growth in this market is mainly driven by the growing requirement for donated blood, the rising number of blood donations around the world, and the ever-increasing infectious diseases. However, operational barriers and the high cost of Blood screening instruments is likely to hamper the growth of blood screening market. Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=267747042 Browse in-depth TOC on "Blood Screening Market" 189 - Tables 45 - Figures 220 – Pages The Reagents & Kits segment is expected to account for the largest share in 2022. Based on product, the blood screening market is segmented into reagents & kits, instruments, and software & services. Increase in demand and contin...

  The   Global Blood Screening Market   in terms of revenue was estimated to be worth $2.4 billion in 2023 and is poised to reach $3.4 billion by 2028, growing at a CAGR of 7.2% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The need for blood is ever-increasing, forcing the number of blood donations to rise as well throughout the world. Combining this factor along with the growing infectious diseases is the major contributor for the growing blood screening market. On the other hand, the unfavorable reimbursement scenario and the high cost of instruments and kits may restrain the growth of this market to a certain extent. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=267747042 Blood screening Market Dynamics Driver: Inc...